Although it has long been known that microinjection of the cholinergic agonist carbachol into the medial pontine reticular formation (mPRF) induces a state that resembles rapid eye movement (REM) sleep, it is likely that other transmitters contribute to mPRF regulation of behavioral states. A key candidate is the peptide vasoactive intestinal polypeptide (VIP), which innervates the mPRF and induces REM sleep when injected into this region of the brainstem. To begin understanding the cellular mechanisms underlying this phenomenon, we examined the effects of VIP on mPRF cells using whole-cell patchclamp recordings in the in vitro rat brainstem slice. VIP directly depolarized cells via activation of an inward current; these effects were attenuated and potentiated in low-sodium and low-calcium medium, respectively. The depolarization induced by VIP was slower in onset and longer-lived than that evoked by carbachol. The VIP-induced depolarization was reduced in a dose-dependent manner by a competitive antagonist of VIP receptors. Effects of VIP were attenuated in the presence of guanosine 5Ј-O-(2-thiodiphosphate, 2Ј5Јdideoxyadenosine, and PKI [15][16][17][18][19][20][21][22][23][24] and were nonadditive in the presence of 8-bromocAMP. We conclude that VIP excites mPRF neurons by activation of a sodium current. This effect is mediated at least in part by G-protein stimulation of adenylyl cyclase, cAMP, and protein kinase A. These data suggest that VIP may play a physiological role in REM induction by its actions on mPRF neurons.
Vasoactive intestinal peptide (V I P), a 28 amino acid peptide originally isolated from porcine duodenum, has been localized in several brainstem nuclei known to play a vital role in behavioral state control (Sims et al., 1980; Eiden et al., 1982; Sutin and Jacobowitz, 1988) . Microinjection of V I P into the brains of cats, rabbits, and rats induces rapid eye movement (REM) sleep (Drucker-Colín et al., 1984; Obál et al., 1989; Bourgin et al., 1997) . Moreover, microinjection of V I P into a site within the rat medial pontine reticular formation (mPRF) results in long-term enhancement of REM sleep not seen when carbachol is injected at the same site (Bourgin et al., 1997) . Injection of a competitive VIP antagonist in rats reduces the amount of time spent in REM sleep during the light period, when rats normally exhibit the highest levels of REM (Mirmiran et al., 1988) , and intracerebroventricular injection of V I P antibodies blocks REM sleep in rats (Riou et al., 1982) . Finally, it has been shown that injection of VIP into the mPRF restores REM sleep in cats rendered insomniac with the serotonin synthesis inhibitor parachlorophenylalanine (PC PA) (Prospero-García et al., 1993) .
Despite the in vivo evidence that V I P may be involved in behavioral state control, few studies have examined the electrophysiological effects of V I P on neurons in brainstem nuclei implicated in the control of the sleep-wakefulness cycle. Wang and Aghajanian (1990) found that VIP induces an increase in EPSP activity in the locus ceruleus (LC), but the in vivo effects of VIP on REM sleep induction are unlikely to be caused by excitation of LC neurons as these neurons are silent during REM (Aston-Jones and Bloom, 1981) . Moreover, the dominant hypothesis in the field suggests that activation of neurons in the mPRF induces REM sleep and that this effect is mediated by activation of cholinergic receptors (Baghdoyan et al., 1993) . Indeed, during naturally occurring REM sleep, the majority of mPRF neurons depolarize 7-10 mV (Ito and McCarley, 1984) , and the cholinergic agonist carbachol depolarizes the majority of mPRF neurons . Because VIP microinjections stimulate REM sleep in a manner highly reminiscent to that seen with cholinergic agonists (Bourgin et al., 1997) , we examined effects of this peptide on the membrane properties of mPRF neurons at a site that has been shown to be critical for the induction of REM sleep. Our data indicate that VIP may play a role in the promotion of REM sleep.
MATERIALS AND METHODS
Wistar rats (7-to 18-d-old; average age, 12 d) were anesthetized with halothane and decapitated. The brain was rapidly removed and trimmed to form a block that contained the mPRF, which was then cut into 400-m-thick coronal slices on an Oxford (Concord, M A) vibratome. The slice containing the mPRF was placed in a recording chamber and superf used with a solution of standard artificial C SF (AC SF) containing (in mM): 126 NaC l, 25 NaHC O 3 , 1.2 NaH 2 PO 4 , 2.5 KC l, 2.5 C aC l 2 , 1.2 MgC l 2 , and 11 glucose, pH 7.3 when saturated with 95% O 2 -5% C O 2 . Slices were allowed to equilibrate to room temperature, and all electrophysiological experiments were performed at 21°C.
The whole-cell configuration of the patch-clamp technique as applied to brain slices was used to record from neurons in the mPRF using bridge mode and voltage-clamp methodologies (Kamondi et al., 1992) . Bridge mode and single-electrode voltage-clamp measurements were obtained with an Axoclamp 2A amplifier (Axon Instruments, Foster C ity, CA) and were filtered at 1 kHz. Access resistance was monitored and considered acceptable when in the range of 10 -50 M⍀. Patch pipettes were constructed from thin-walled borosilicate glass capillary tubes (outer diameter, 1.5; inner diameter, 1.17) (Warner Instruments, Hamden, C T). The electrode solution contained (in mM): 120 K-gluconate, 10 H EPES acid, 24 NaC l, 15 KC l, 11 EGTA, 1 C aC l 2 , and 2 MgATP.
For voltage-command generation and voltage and current data acquisition, the pC lamp 6 suite of programs (Axon Instruments) was used. In bridge mode, baseline and postdrug recording of input resistance and membrane potential of mPRF neurons were collected and compared; input resistance was determined by maximum voltage deflection of the membrane potential after the injection of 0.03 nA of hyperpolarizing current either at the resting potential, or in the case of drug effects, after injection of direct current (DC) to bring the cell to resting membrane potential. In additivity experiments, peak induced depolarization or inward current were used as the index of response. Data are reported as mean Ϯ SEM. Statistical significance was assessed using the Student's paired t test or a between-group repeated-measure ANOVA. In histograms, V I P-induced inward currents were normalized (100% Ϯ SEM) and considered "control"; drug treatments are expressed as a percentage Ϯ SEM of this normalized current.
V I P was obtained from Sigma (St. L ouis, MO) and dissolved at 100 M in 0.01 M acetic acid and frozen. On the day of the experiment, an aliquot was diluted to a final concentration of 100 nM in AC SF; control experiments revealed that application of 10 M acetic acid (the final concentration) in AC SF did not elicit noticeable effects on cells. Applications of V I P were either via the bath (total application time of 30 sec) or usage of a General Valve (Fairfield, NJ) Picospritzer II (200 msec pulse duration). It should be noted that pretreatment of the puffer pipette and the inflow tubing was not performed; potential alterations in concentration of the peptide delivered to the slice because of binding of the peptide to these surfaces were not investigated. (D-P-chloro-Phe 6 , Leu 17 )-vasoactive intestinal peptide (DPC -V I P), a V I P receptor antagonist (Sigma), was applied at a concentration of 250 -500 nM.
In most experiments, tetrodotoxin (TTX) (Sigma) was added to block voltage-dependent sodium currents. L ow-sodium (27.2 mM) solution was made by equimolar substitution of choline chloride for NaC l. In these experiments, the muscarinic receptor antagonist atropine (5 M; Sigma) was added to AC SF-choline to prevent the depolarization produced by choline itself; as a control, the effects of V I P in atropine-containing AC SF were also examined (control AC SF) and were not found to be different from those in nonatropine-containing AC SF. L ow-calcium (0.5 mM) solutions, made by substitution of calcium with high magnesium (10 mM), were applied for 10 -20 min before drug application; efficacy was monitored by observing a reduction of the amplitude of the calciumdependent after hyperpolarization (AHP). In experiments using cesium to block the hyperpolarization-activated cationic current (I h ) and inwardly rectif ying potassium currents, cesium was added directly to the AC SF at a final concentration of 1 mM.
8-bromo-cAM P and 8-bromo-cGM P (Sigma) were dissolved in AC SF and applied for 20 min. Stock solutions of 2Ј5Јdideoxyadenosine (DDA) (1 mM dissolved in dimethyl sulfoxide; C albiochem, La Jolla, CA), LY 83583 (10 mM dissolved in dimethyl sulfoxide; C albiochem), and RP-8-pC P T-cGM PS (1 mM dissolved in water; Biolog, Hay ward, CA) were diluted in AC SF and applied for 10 -20 min. Guanosine 5Ј-O-(2-thiodiphosphate) (GDP-␤-S) (Sigma), a phosphorylation-and hydrolysisresistant analog of GDP, was dissolved in the pipette solution. PK I 15-24 (C albiochem) was also dissolved in the pipette solution, and ejection into the cell was facilitated by passing pulses of positive current (0.03 nA; duration of 750 msec) for 15-20 min. In these latter two experiments, effects of V I P were tested immediately after cell penetration and then repeated after allowing diff usion of the antagonists into the cell.
RESULTS
A total of 133 neurons within the mPRF (corresponding to the posterior area of the pontis oralis at the level of the trigeminal motor nucleus in the rat) were studied. Preliminary data indicated that 100 nM V I P induced maximal effects on membrane potential and current in these cells; higher concentrations only increased the duration of the effect. Effects were reproducible with no attenuation in the same cell after recovery.
The effects of VIP on mPRF neurons were examined in bridge mode in 35 cells. There was no significant difference between bath application and picospritzer delivery ( p Ͼ 0.05; ANOVA), and therefore these data were pooled. Bath and picospritzer application of VIP (100 nM) depolarized 31 of 35 mPRF neurons by 3.27 Ϯ 0.04 mV ( p Ͻ 0.05) with a concurrent decrease in input resistance of 47.7 Ϯ 0.18 M⍀ ( p Ͻ 0.05) ( Fig. 1 A, B) ; this represents a change in input resistance of 15%. In no case did VIP elicit hyperpolarization of mPRF cells. The onset to depolarizing effects of VIP was 1.86 Ϯ 0.23 min, and latency to peak effect was 4.23 Ϯ 0.38 min. The duration of the depolarizing effect was 8.5 Ϯ 0.2 min. Application of TTX (n ϭ 14) before VIP did not block either the depolarization or change in input resistance. These data indicate that the effects of VIP on mPRF cells is not dependent on action potential generation in the slice.
Carbachol (1 M) depolarized 13 of 14 mPRF neurons 6.10 Ϯ 0.32 mV, which had previously depolarized in response to VIP Figure 1 . V I P depolarizes mPRF neurons; carbachol also elicited membrane depolarization in a subpopulation of these cells. A, Top traces represent current. Bottom traces represent membrane potential. A 30 sec bath application of 100 nM VIP (solid bar) resulted in a depolarization and a decrease in input resistance. After recovery from the VIP-induced depolarization, carbachol depolarized this cell. B, Averages of 10 voltage responses to hyperpolarizing current pulses before V I P ( 1), during the peak effect of V I P but with the cell returned to the resting membrane potential by the injection of hyperpolarizing DC current ( 2), and after washout of V I P ( 3). A superimposition of traces in 1 and 2 are presented in 4 to show the difference in input resistance elicited by VIP. C, Schematic representation of coronal sections of the brainstem showing the region within the mPRF at which effects of V I P were examined (circles). DR, Dorsal raphe nucleus; Mo5, motor trigeminal nucleus.
and recovered (Fig. 1 A) . The latency to onset of effect was 18.0 Ϯ 3.0 sec, and latency to peak was 1.7 Ϯ 0.17 min. In three cells, VIP was applied first and carbachol added during peak effects, which resulted in f urther depolarization (data not shown). These data, coupled with those of Greene et al. (1989) that demonstrated that carbachol depolarized most mPRF cells via activation of a nonrectif ying potassium conductance, as well as activating an inwardly rectif ying potassium conductance in a minority of mPRF cells that hyperpolarized in response to carbachol, suggest that distinct mechanisms underlie the V I P-and carbacholinduced depolarizations.
To test the hypothesis that V I P was acting at V I P receptors, the effects of the competitive V I P antagonist DPC -VIP were studied. The protocol used was begun with a control application of VI P, and after washout, pretreatment with DPC -VIP and reapplication of V I P; when possible, the control application of VIP was repeated at the conclusion of the experiment. In the presence of 250 nM DPC -V I P, V I P induced only 50.2 Ϯ 0.31% of maximum depolarization and 41.0 Ϯ 0.23% of maximum change in input resistance, respectively (n ϭ 4), and, in the presence of 500 nM DPC -V I P, 82.5 Ϯ 0.21 and 79.3 Ϯ 0.6% of V I P-induced depolarization and input resistance changes were suppressed (n ϭ 3) (Fig. 2) .
In voltage-clamp mode, 100 nM V I P induced an inward current of 98.3 Ϯ 13.9 pA at Ϫ60 mV (n ϭ 18), with an accompanying increase in conductance (Fig. 3 A, B) . The V I P-induced inward current was not mediated by a decrease in potassium conductance because the control and V I P I-V curves did not cross at the potassium reversal potential (Fig. 3C) , nor was the current mediated by a change in chloride conductance because I-V curves did not cross at the chloride equilibrium potential. Blockade of the hyperpolarization-activated cation current (I h ) by 1 mM cesium did not significantly alter the effect of V I P on mPRF neurons in either bridge mode (n ϭ 5; p Ͼ 0.05) or voltage clamp (n ϭ 2; p Ͼ 0.05) (Fig. 4 B) . Although not readily apparent in Figure 4 , the change in conductance (voltage clamp) or input resistance (current clamp) was not significantly different in the two conditions (control -V I P and cesium -V I P) in the population of cells examined ( p Ͼ 0.05). These data, together with the observation that the I-V curves do not cross in the region between Ϫ30 and Ϫ70 mV suggest that I h does not play a role in generation of the VIP-induced inward current.
Adequate voltage clamp at potentials more positive that Ϫ30 mV was not possible, precluding the use of I-V curves to study the contributions of the cations calcium and sodium to the VIPinduced inward current. Therefore, VIP was applied in ACSF containing altered concentrations of these ions. Low-calcium solution (5 mM) applied for at least 15 min, resulting in reduction of the calcium-dependent AHP , Fig. 4C ), did not block the VIP-induced depolarizations and inward current (n ϭ 12). Indeed, the depolarization and inward current induced by VIP in the presence of low-calcium solution was significantly increased ( p Ͻ 0.05) (Fig. 4C,D) . Reducing the concentration of sodium to 26 mM in the ACSF significantly reduced both the VIP-induced inward current (n ϭ 4; p Ͻ 0.05) and depolarization (n ϭ 10; p Ͻ 0.05) without attenuation of an accompanying increase in conductance (11%) and decrease in input resistance, respectively, which was not significantly different from that seen in control conditions (12.3%; p Ͼ 0.05) (Fig. 4 A, E) .
cAMP mediates the effects of VIP
To test the hypothesis that the inward current and depolarization induced by VIP may be dependent in part on activation of cAMP-dependent mechanisms, we applied agonists and antagonists of this second messenger system. Passive diffusion of the phosphorylation-and hydrolysis-resistant GDP analog GDP-␤-S (20 M) from the recording electrode into the cell gradually hyperpolarized the membrane potential and significantly reduced the amplitude of the inward current and depolarization induced by VIP (n ϭ 6; p Ͻ 0.05) (Fig. 5A-C) . The effects of GDP-␤-S were not likely to be caused by the hyperpolarization per se, because recordings obtained from a subset of mPRF cells with a mean resting membrane potential of Ϫ72 Ϯ 3.2 mV (n ϭ 8) showed that VIP-induced effects were not statistically different from cells with more depolarized membrane potentials.
The membrane permeable adenylyl cyclase inhibitor DDA (50 -100 M) reduced the amplitude of the VIP response in five of five cells tested. DDA induces an increase in input resistance, membrane hyperpolarization, and outward current; application of VIP in the presence of DDA resulted in a reduction of both the VIP-induced depolarization (63.8 Ϯ 0.7% reduction; n ϭ 3; p Ͻ 0.05) (Fig. 5D ) and inward current (71.2 Ϯ 0.5% reduction; n ϭ 3; p Ͻ 0.05) (Fig. 5E ) compared with control.
Application of the membrane permeable cAMP analog 8-bromo-cAMP depolarized all mPRF neurons via activation of Figure 2 . The V I P-induced depolarization was antagonized by the V I P-receptor antagonist DPC-VIP in a dose-dependent manner. A, Bridge mode recordings from one mPRF neuron in which 100 nM VIP was applied for 30 sec ( first trace). After recovery (25 min), 100 nM V I P was added in the presence of 250 nM DPC -V I P (second trace). After washout (25 min), 100 nM V I P was added in the presence of 500 nM DPC -V I P (third trace). After washout of DPC-VIP (20 min), 100 nM V I P without antagonist was applied. Black bars in each trace indicate application of VIP. B, Dose-dependent attenuation of VIPinduced depolarization by DPC -V I P. . VIP induces a sodium-dependent depolarization. A, Bridge mode recordings of the response of a cell to 100 nM V I P in the presence of choline-substituted low-sodium AC SF. After washout of the low-sodium solution, V I P application was repeated in the presence of control ACSF. Calibration: 5 mV, 1 min. B, V I P (100 nM) applied for 30 sec in the presence of 1 mM cesium (top trace) induced an inward current that was not significantly different from in control conditions (bottom trace). C, Bridge mode recordings of the response to 100 nM V I P applied for 30 sec in normal ACSF (top trace) and after washout in 0.5 mM Ca an inward membrane current (Fig. 6 A) . The inward current induced by 1 mM 8-bromo-cAM P and that induced by VIP were not additive (n ϭ 5) (Fig. 6 A) , which is consistent with the hypothesis that V I P induces an inward current in mPRF neurons by activating the cAM P pathway. However, because direct antagonists of cAM P were not used, we have not formally ruled out the hypothesis that cAM P does not have direct actions, such as activation of sodium channels, thereby preventing V I P-activation of these channels by protein kinase-dependent mechanisms (see below).
The intracellular application of the PK A inhibitor PKI [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] (1 mg/1 ml) reduced the amplitude of V I P-induced depolarization (19 -35 min; 55.2 Ϯ 0.1% mV reduction; n ϭ 2; p Ͻ 0.05) (Fig.  6 B) and that of the V I P-induced inward current. Effects of VIP on subsequent applications were f urther attenuated (19 -35 min; 61.0 Ϯ 0.11% pA of control; 46 -59 min; 23.0 Ϯ 0.12% pA of control; n ϭ 7; p Ͻ 0.05) (Fig. 6C,D) . Because V I P has also been reported to induce cGM P activity in some neuronal cell types (Ho et al., 1987; Chik et al., 1988) and because the cAMP cascade is well known to interact with cGMP pathways, we also examined the effects of VIP on mPRF neurons in the presence of 1 mM 8-bromo-cGMP. 8-bromo-cGMP hyperpolarized or induced an outward current in 8 of 10 cells and induced an inward current in two additional cells; the depolarization or inward current induced by VIP in the presence of 8-bromo-cGMP in these cells was not significantly different from that induced by VIP in control conditions in the same cells (n ϭ 10; p Ͼ 0.05) (Fig. 7 A, C) .
We also examined the effects of VIP on induction of inward current in the presence of the soluble guanylyl cyclase inhibitor LY 83583. During the first 2 min of application, 10 M LY 83583 induced an outward current in five of seven cells examined. However, after this initial effect, a slowly developing inward current developed in these cells; in two of seven cells, an inward current was induced only. LY 83583 did not attenuate VIPinduced inward current (Fig. 7 A, C) .
We next examined the effects of VIP in the presence of the Figure 5 . The V I P-induced depolarization is mediated by G-protein-dependent activation of adenylyl cyclase. A, Effects of 100 nM V I P, 30 sec, applied 90 sec after breaking into a cell with a pipette containing 20 M GDP-␤-S (top trace; membrane potential, Ϫ62.5 mV) and after washout 27 min after break-in (bottom trace; membrane potential, Ϫ68.3 mV). B, In voltage clamp, effects of a 20 sec application of 100 nM V I P administered 160 sec after breaking into a cell with a pipette containing 20 M GDP-␤-S and 22 min after break-in. C, Histogram of the normalized inward current activated by V I P within 3 min of cell entry and 17-25 min after entry when GDP-␤-S is included in the pipette (n ϭ 6). DDA (50 M) blocked both the depolarization ( D) and inward current ( E) induced by V I P.
competitive inhibitor of cGM P-dependent protein kinases Rp-8-pCPT-cGM Ps (10 M). After 15 min of application of this cGMP inhibitor, V I P was applied and found to induce a significantly greater inward current than that induced during control conditions (132.0 Ϯ 0.9%; n ϭ 3; p Ͻ 0.05) (Fig. 7 B, C) . These data suggest that cGM P mechanisms are not involved in the VIPinduced inward current.
DISCUSSION
The principal finding of the present study is that V I P depolarizes a population of mPRF neurons. The effects of V I P persisted in the presence of both TTX and reduced calcium, suggesting that they are mediated by receptors located on this population of brainstem cells. The V I P-mediated depolarization was reduced in a dose-dependent manner by a V I P receptor antagonist. Several lines of evidence suggest that the V I P-induced inward current did not arise secondary to a shift in the activation curve of I h . We found that, whereas 8-Br-cAM P shifts the I h activation curve of mPRF cells to more depolarized potentials (our unpublished observations) as has been reported in thalamic cells (McCormick and Pape, 1990) , V I P at the concentrations used in the present study does not have this effect. Moreover, the V I P-induced inward current persisted in the presence of cesium, which has been reported to be an effective blocker of I h (McCormick and Pape, 1990), nor is it likely that VIP was acting via inhibition of the Na-K pump. VIP-induced effects were accompanied by conductance changes in normal ACSF; inward currents induced by Na-K pump inhibition are associated with little change in conductance (Gadsby and Nakao, 1989; Hermans et al., 1994) . The extrapolated reversal potential calculated from I-V curves of the VIP-induced current was ϳ0 mV, an observation that would not be expected if the VIP effects were mediated by inhibition of a pump. Most importantly, inward currents induced by inhibition of the pump would be expected to be enhanced in the presence of reduced extracellular sodium (Kuba and Nohmi, 1987; Wang and Aghajanian, 1989; Shen and Johnson, 1998) , whereas the VIPinduced inward current was diminished under similar conditions. The persistence of the effects of VIP in TTX suggests that the effects of VIP are not mediated by classical voltage-dependent sodium channels. Under voltage-clamp conditions, the VIPinduced depolarization was found to be mediated by an inward current that was long lasting and accompanied by an increase in conductance. Failure of the control and VIP I-V curves to cross at the potassium or chloride reversal potentials suggests that VIP effects were not mediated by these two ions. Ion substitution experiments were consistent with the hypothesis that VIP effects were caused by an increase in a sodium current. However, be- cause specific pharmacological blockade of potassium conductances were not performed, we cannot rule out the hypothesis that other conductance changes contribute to the V I P-mediated depolarization. Moreover, these effects of V I P were shown to be mediated, at least in part, by activation of the cAM P cascade. Because excitation of mPRF neurons has been suggested to be critical in the generation of REM sleep, these data suggest that VIP may play a role in regulation of REM sleep by actions on mPRF neurons specifically during this behavioral state. It has long been known that microinjection of cholinergic agonists within the mPRF can produce a state that is behaviorally indistinguishable from naturally occurring REM sleep (Baghdoyan et al., 1993) . The ability to induce REM using pharmacological techniques has served as a powerf ul tool with which to study the mechanisms of state generation. Although a strong body of evidence supports the notion that cholinergic mechanisms are involved in triggering REM sleep (Kodama et al., 1990; Baghdoyan et al., 1993) , cholinergic excitation of the mPRF is not likely to be the only mechanism by which REM is induced. For example, injections of the neutral endopeptidase inhibitor phosphoramidon into the mPRF results in a REM-like state (Morales et al., 1998) , suggesting that increased survival of an endogenous peptide released within the mPRF elicits REM sleep. Moreover, cholinergic antagonists modif y, but do not block, the occurrence of natural REM sleep (Gnadt and Pegram, 1986; Imeri et al., 1991) . Thus, transmitters other than acetylcholine also appear to be involved in triggering REM sleep in the mPRF. One candidate is the peptide V I P. Microinjection of V I P into the "REMinduction site" induces REM sleep in cats, rabbits, and rats (Drucker-Colín et al., 1984; Obál et al., 1989; Bourgin et al., 1997) . Our data demonstrating that V I P directly depolarizes mPRF neurons places this observation on a strong mechanistic footing. Moreover, the V I P-induced depolarization was longer in duration than that seen with the long-lasting hydrolyzable cholinergic agonist carbachol. It is possible that naturally released acetylcholine might cause short-term changes in mPRF excitability concurrent with enhancement (via increased resistance of these cells) of EPSPs, resulting in mPRF cells attributable to reticular stimulation, which is a phenomenon seen in naturally occurring REM (Ito and McCarley, 1984) . In a similar vein, it seems plausible that VIP might play a role in the maintenance of the REM state via prolonged depolarization of mPRF cells. Finally, these observations suggest that natural REM sleep may be produced by the concerted release of at least two transmitters, acetylcholine and VIP.
Indirect evidence supports the involvement of VIP in REM generation. VIP restores REM sleep in cats rendered insomniac with the serotonin synthesis inhibitor PCPA; these effects persist in the presence of the muscarinic receptor antagonist atropine, indicating that the REM sleep-restorative effects of VIP were not dependent on cholinergic mechanisms (Prospero-García et al., 1993) . Decreases in REM sleep have been reported in the rat after intraventricular application of VIP antagonists (Mirmiran et al., 1988; Prospero-García et al., 1993) and VIP antibodies (Riou et al., 1982) . In this note, it is interesting to compare the effects of VIP antagonists on REM with those reported for cholinergic antagonists. VIP antagonists have been shown to decrease REM sleep in the rat by 64 and 22%, which was compensated for in both studies by an increase in wakefulness (Riou et al., 1982; Mirmiran et al., 1988) . The results from studies using cholinergic antagonists are less clear. Atropine has been reported to have no effect on naturally occurring REM sleep in rats (Gnadt and Pegram et al., 1986) ; however, it has been reported that the M 2 receptor antagonist methoctramine delays the latency to REM episodes, and, at higher doses, REM was reduced by 75% (Imeri et al., 1991) . VIP receptors have been found to be increased in the mPRF after sleep deprivation (Jimenez-Anguiano et al., 1996) . Finally, Shiromani and McGinty (1986) reported that at least some neurons in the mPRF increased firing in vivo in response to VIP at the same site in which carbachol induced REM sleep. Together with our new data, these reports provide a growing body of evidence that VIP is involved in regulation of the sleep-wakefulness cycle.
VIP has been shown to enhance acetylcholine synthesis in structures such as the hippocampus (Luini et al., 1984) . Additionally, it has been shown that VIP can modulate acetylcholine Figure 7 . The cGM P second messenger system does not appear to be involved in V I P-induced inward currents. A, 8-bromocGM P induces an outward current in this cell (top trace). V I P-induced inward current is not significantly different in the presence of 8-bromo-cGM P than in control conditions ( C). The reversible guanylyl cyclase inhibitor LY 83583 does not block activation of inward current by V I P (bottom trace and C). B, RP-8-pC P T-cGM PS, an inhibitor of cGM P formation, did not block the VIPinduced inward current but significantly increased it ( C).
actions (Halimi et al., 1997) . These data can be interpreted as evidence that in vivo actions of V I P on the induction of REM sleep may be dependent on the effects of V I P on mPRF cholinergic tone. V I P has also been shown to modif y muscarinic, as well as nicotinic, receptor f unction (Mo and Dun, 1984; Kawatani et al., 1985; Pedigo and Rice, 1992; Gurantz et al., 1994; Cuevas and Adams, 1996) . Effects of V I P on induction of REM sleep appear to be independent of muscarinic receptor activation, although this study was conducted in PC PA-treated animals, which may confound these conclusions (Prospero-García et al., 1993) ; however, effects of V I P after release of acetylcholine onto mPRF neurons or on mPRF nicotinic receptors f unction remain unknown. The notion that V I P may modif y REM sleep via such effects is particularly interesting in light of the findings that microinjection of nicotine into the mPRF have been found to elicit REM sleep (Velazquez-Moctezuma et al., 1990) . Regardless, although effects of V I P on cholinergic tone or enhancement of muscarinic or nicotinic receptor f unction may contribute to VIP-inducement of REM sleep in vivo, the present data clearly indicate V I P directly excites mPRF neurons.
VIP-positive fibers have been found within the mPRF (Sims et al., 1980; Eiden et al., 1982) , but the source of these fibers has not been determined. V I P has been found in the noncholinergic cells of the laterodorsal tegmental nuclei (LDT) and at higher numbers in the pedunculopontine tegmental nuclei (PP T), as well as in the most dorsal aspect of the mPRF (Sutin and Jacobowitz, 1988) . Although both cholinergic and noncholinergic LDT and PPT neurons project to the mPRF, it has not been formally demonstrated that V I P-positive cells project to the mPRF from these structures. However, it is clear that V I P receptors are found in the mPRF (Staun-Olsen et al., 1985) . These anatomical data suggest that our pharmacological findings have physiological relevance and support the hypothesis that V I P may be involved in the mechanisms that trigger REM sleep.
Several phenomena that regulate peptide release are relevant to these data. Nitric oxide, produced in cholinergic PP T and LDT neurons, is thought to be generated during REM (Kamondi et al., 1992; Leonard and Lydic, 1997) , and nitric oxide has been shown to stimulate the release of V I P (Grider, 1993; Grider and Jin, 1993) . Thus, release of nitric oxide in the mPRF during REM may modif y release of V I P. Moreover, peptide release is facilitated by high-frequency firing (L undberg and Hökfelt, 1986) . A subpopulation of LDT and PP T cells exhibit burst firing just before the transition to REM and continuing during the entire episode, and it has been suggested that these cells are noncholinergic (Steriade et al., 1990) . If these neurons contain VIP, such burst firing would be the appropriate stimulus for peptide release.
